Literature DB >> 19641271

Continuous opioid treatment for chronic noncancer pain: a time for moderation in prescribing.

Stephen Colameco1, Joshua S Coren, Carman A Ciervo.   

Abstract

Physicians have embraced the concept of long-term opioid treatment for chronic noncancer pain (CNCP), as evidenced by increased prescribing. Many patients have benefited from more liberal opioid prescribing, but many have not, and prescription opioid abuse has risen significantly coincident with increased prescribing. Because of the potentially serious adverse effects of opioids, physicians must balance potential benefits against risks, especially in individuals at risk for opioid misuse, abuse, or dependence. This article reviews long-term, continuous opioid treatment of CNCP, current treatment guidelines, addiction risk stratification, opioid-induced hyperalgesia, and endocrine dysfunction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19641271     DOI: 10.3810/pgm.2009.07.2032

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  2 in total

1.  MicroRNAs Are Involved in the Development of Morphine-Induced Analgesic Tolerance and Regulate Functionally Relevant Changes in Serpini1.

Authors:  Jenica D Tapocik; Kristin Ceniccola; Cheryl L Mayo; Melanie L Schwandt; Matthew Solomon; Bi-Dar Wang; Truong V Luu; Jacqueline Olender; Thomas Harrigan; Thomas M Maynard; Greg I Elmer; Norman H Lee
Journal:  Front Mol Neurosci       Date:  2016-03-24       Impact factor: 5.639

2.  The cardio-metabolic impact of taking commonly prescribed analgesic drugs in 133,401 UK Biobank participants.

Authors:  Sophie Cassidy; Michael I Trenell; Kirstie N Anderson
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.